Introduction {#sec1}
============

SLITs are a conserved family of secreted proteins that participate in numerous developmental processes by signaling through ROBO receptors expressed on diverse cell types ([@bib3]). The bilayered ducts of the mammary gland (MG) comprise an outer layer of basal cells (BCs) and an inner layer of luminal cells (LCs) and grow into a tree-like structure ([@bib14]). SLITs, expressed throughout the gland, regulate the elongation and branching of this structure during puberty by limiting the proliferation of basal cap cells ([@bib15; @bib23]). BCs are capable of generating an entire mammary epithelial tree when transplanted into a cleared fat pad ([@bib21; @bib22]). However, this population is heterogeneous, containing a small subset of MaSCs and a majority of differentiated cells. Little is known about mechanisms that regulate the growth, survival, and senescence of the basal MaSCs (bMaSCs).

SLITs regulate cell proliferation in both normal BCs and breast cancer cells by inhibiting AKT, leading to activation of GSK3β, and resulting in reduced nuclear accumulation of β-catenin and decreased expression of WNT-activated genes ([@bib15; @bib19; @bib25]). Inhibition of β-catenin and canonical WNT signaling by SLIT may be important in regulating MaSC numbers because WNT3A enhances the self-renewal capacity of bMaSCs in culture, stimulating their clonal expansion while maintaining their ability to generate functional glands upon transplantation ([@bib26]). Although expression of WNT1 or activated β-catenin results in an expanded bMaSC population and enhanced tumor formation ([@bib21; @bib24]), less is known about the impact of inhibiting WNT signaling. However, treatment of bMaSCs with the WNT inhibitor DKK decreases formation of secondary colonies, presumably by limiting self-renewal ([@bib26]). Therefore, curbing WNT signaling through SLIT/ROBO signaling may also restrict bMaSC self-renewal.

MaSC numbers must be tightly regulated through a balance of self-renewal, differentiation, and senescence to prevent tumorigenesis, while accommodating high levels of cell proliferation during pregnancy. Several secreted factors such as WNT and Hedgehog promote self-renewal, but little is known about how this process is restricted ([@bib5; @bib13; @bib26]). Mechanisms involving p53 signaling have been demonstrated, in which bMaSC self-renewal is limited by either inhibiting symmetric divisions ([@bib6]) or increasing senescence ([@bib11]). Additionally, inhibiting WNT signaling by DKK upregulates senescence-associated cell cycle inhibitor, p16 ^INK4a^ (CDKN2A) ([@bib5]), which is directly repressed by β-catenin ([@bib8]). Here, we hypothesize that SLITs influence the self-renewal of bMaSCs by regulating their senescence. Our investigation identifies SLIT as an extracellular factor that signals through its ROBO2 receptor to inhibit WNT signaling, thereby regulating bMaSC senescence by governing the subcellular localization of β-catenin. As such, SLITs are a class of nonrenewal factors for bMaSCs in the MG.

Results {#sec2}
=======

Loss of Robo2 Enhances bMaSC Self-Renewal In Vitro {#sec2.1}
--------------------------------------------------

To investigate the regulation of bMaSCs by SLIT/ROBO signaling, we examined expression of the *Robo1* and *Robo2* receptors in flow cytometry (FACS)-purified BCs (Lin-CD24^+^CD29^hi^), mature luminal cells (Lin-CD24^lo^CD29^+^CD61^−^; ML), and luminal progenitor cells (Lin-CD24^lo^CD29^+^CD61^+^; LP), harvested from the mature virgin MG. Quantitative RT-PCR (qRT-PCR) analysis shows expression of *Robo1* and *Robo2* in BCs, with a significant enrichment of *Robo2* expression in BCs as compared to the ML and LP populations ([Figures 1](#fig1){ref-type="fig"}A and 1B). We have previously published the localization of ROBO1 on cap/BCs and a subpopulation of LCs ([@bib15; @bib16]). To further confirm ROBO2 expression, we performed immunohistochemistry (IHC) and find ROBO2 expression in subpopulations of BCs and LCs in vivo ([Figure 1](#fig1){ref-type="fig"}C) and in vitro ([Figure 1](#fig1){ref-type="fig"}D).

To determine if loss of SLIT/ROBO signaling leads to changes in the self-renewal capacity of bMaSCs, we examined the ability of *Robo1*^*−/−*^ or *Robo2*^*−/−*^ FACS-purified BCs to serially passage in 3D Matrigel colony assays. Wild-type (WT) BCs possess a limited capacity for self-renewal ([Figures 1](#fig1){ref-type="fig"}E and 1G), with colonies progressively becoming smaller until they senesce at passages 4--5 ([Figures 1](#fig1){ref-type="fig"}F and 1H). Loss of *Robo1* does not confer an advantage in passaging ability or colony size ([Figures 1](#fig1){ref-type="fig"}E and 1F). In contrast, loss of *Robo2* leads to an increase in passaging ability ([Figure 1](#fig1){ref-type="fig"}G) and reduces the decline in colony size over passage ([Figures 1](#fig1){ref-type="fig"}H--1J), suggesting that loss of *Robo2* enhances bMaSC self-renewal.

SLIT2 Acts as a Nonrenewal Factor by Inhibiting β-Catenin Activity in bMaSCs {#sec2.2}
----------------------------------------------------------------------------

The enhanced self-renewal observed in *Robo2*^*−/−*^ BCs suggests that SLIT2 acts through ROBO2 to inhibit self-renewal. To test this, BCs were treated with SLIT2 during the initial plating and then grown in the absence of SLIT2 in subsequent passages ([Figures 2](#fig2){ref-type="fig"}A and 2B). Analysis of SLIT2-treated colonies at P1 reveals significantly smaller colonies compared to control ([Figure 2](#fig2){ref-type="fig"}B). 5-ethynyl-2′-deoxyuridine (EdU) incorporation was also significantly reduced in SLIT2-treated colonies, compared to control (data not shown). These data are consistent with our previous finding that SLIT2 acts through ROBO1 to inhibit BC proliferation ([@bib15]). We next determined whether bMaSCs continue to self-renew when released from the antiproliferative activity of SLIT2. Despite the absence of exogenous SLIT2, BCs, initially treated with SLIT2, are unable to self-renew and continue to exhibit impaired proliferation as indicated by colony size ([Figures 2](#fig2){ref-type="fig"}A and 2B). These data support the hypothesis that SLIT2 acts not only to inhibit BC proliferation, but also as a bMaSC nonrenewal factor.

Canonical WNT signaling enhances the self-renewal of bMaSCs ([@bib26]). To determine if SLIT2 acts as a nonrenewal factor by inhibiting the WNT pathway, BCs were treated with SLIT2, WNT3A, or both. Initial colony number, assessed at passage 1 (P1), is similar between all treatment groups, although colonies treated with SLIT, even in the presence of WNT3A, are smaller in size ([Figure 2](#fig2){ref-type="fig"}C; data not shown). As previously published, colonies treated with WNT3A alone show a marked increase in colony number ([@bib26]). Again, colonies treated with SLIT2 alone cannot be passaged past P2, even at a lower SLIT2 concentration. Treatment with both SLIT2 and WNT3A greatly attenuates self-renewal as indicated by reduced cumulative colony numbers. Taken together, these data suggest that SLIT2 inhibits WNT-mediated self-renewal.

Previous research has shown that SLIT2 opposes WNT signaling by regulating the AKT/GSK3β pathway and inhibiting the nuclear localization of β-catenin ([@bib15; @bib19; @bib25]). We next examined whether loss of SLIT/ROBO2 signaling results in enhanced β-catenin activity in BC colonies by examining localization of the activated form of β-catenin (ABC) ([Figures 2](#fig2){ref-type="fig"}D and 2E). In *Robo2*^+/+^ colonies, ABC is localized primarily to the membrane and throughout the cytoplasm. In contrast, *Robo2*^−/−^ colonies have a more diffuse localization of ABC. Although levels are similar in the cytoplasm, less ABC is localized to the membrane. Because β-catenin is only transcriptionally active in the nucleus, we also analyzed nuclear ABC, as determined by colabeling with Hoechst, and found a significant increase in *Robo2*^−/−^ colonies. Although we did not examine whether increased nuclear ABC is localized specifically in BCs, analysis of colony composition using BC marker K14 and LC marker K8 shows the majority of cells (60%--70%) in both *Robo2*^+/+^ and *Robo2*^*−/−*^ colonies are K14^+^ (data not shown). This, in conjunction with our finding that ROBO2 colocalizes with BC marker p63 in *Robo2*^+/+^ colonies ([Figure 1](#fig1){ref-type="fig"}D), suggests that loss of *Robo2* is likely regulating β-catenin signaling in at least a subpopulation of BCs. To determine if increased nuclear β-catenin leads to upregulation of stem cell related target genes, we examined transcriptional levels of *Myc*, *Jun*, and *Tert* ([@bib10; @bib12; @bib17]). We find that all three genes show increased expression in *Robo2*^*−/−*^ BC colonies, although only *Myc* reaches significance ([Figure 2](#fig2){ref-type="fig"}F). Together, these data suggest that loss of *Robo2* leads to increased β-catenin signaling in BC colonies.

To determine if increased nuclear ABC in *Robo2*^*−/−*^ BC colonies is due to loss of SLIT/ROBO2 signaling and not the result of a compensatory increase in canonical WNT signaling, we examined the consequences of blocking WNT signaling ([Figure 2](#fig2){ref-type="fig"}G). DKK1 is a secreted factor that inhibits WNT signaling upstream by interfering with LRP5/6 receptor function, and it has been shown to inhibit BC colony self-renewal ([@bib26]). Accordingly, we find that treatment of *Robo2*^+/+^ colonies with DKK1 leads to reduced secondary colony formation; however, *Robo2*^*−/−*^ colonies are resistant to DKK1 treatment and exhibit a significant increase in secondary colony formation ([Figure 2](#fig2){ref-type="fig"}G). These results show that inhibition of WNT signaling via DKK1 is insufficient to block self-renewal in bMaSCs that have lost SLIT/ROBO2 signaling. The fact that in the absence of *Robo2* there is increased nuclear β-catenin ([Figures 2](#fig2){ref-type="fig"}D and 2E), along with enhanced BC colony renewal ([Figure 1](#fig1){ref-type="fig"}G), even under DKK1 treatment conditions ([Figure 2](#fig2){ref-type="fig"}G), suggests that the loss of SLIT/ROBO2 enhances bMaSC renewal directly by increasing nuclear β-catenin signaling. To further examine if stem cell renewal is increased in *Robo2*^*−/−*^ cells through activation of the PI3K/AKT/GSK-β pathway, we treated *Robo2*^*+/+*^ and *Robo2*^*−/−*^ colonies with AKT inhibitor LY294002 ([Figure 2](#fig2){ref-type="fig"}H). We find that AKT inhibition significantly impedes renewal in *Robo2*^*−/−*^ colonies, suggesting that the PI3 kinase pathway is indeed a key pathway promoting β-catenin-mediated self-renewal in the absence of ROBO2.

SLIT2/ROBO2 Signaling Promotes bMaSC Senescence by Derepressing P16 ^INK4a^ Expression {#sec2.3}
--------------------------------------------------------------------------------------

The results from the serial passaging assay suggest that one possible mechanism through which SLIT2 acts as a nonrenewal factor is by promoting senescence in bMaSCs and their offspring. P16^INK4a^ is a cell-cycle inhibitor that mediates cellular senescence. Previous studies show that β-catenin immortalizes skin melanocytes by directly binding to and silencing the *p16*^INK4a^ promoter ([@bib8]). We first looked at expression of *p16* ^*INK4a*^ by qRT-PCR and, although both *Robo2*^*+/+*^ and *Robo2*^*−/−*^ colonies have higher levels of *p16*^*INK4a*^ at P4 compared to P1, *Robo2*^*−/−*^ colonies have significantly attenuated levels ([Figure 3](#fig3){ref-type="fig"}A). Next, we evaluated p16^INK4a^ at passages P1 and P4 by IHC ([Figures 3](#fig3){ref-type="fig"}B--3D). At P1, little p16^INK4a^ expression is observed (not shown), but at P4, significantly higher levels of p16 are detected in both the cytoplasm and nucleus of WT colonies, whereas its expression is significantly lower in *Robo2*^*−/−*^ colonies ([Figure 3](#fig3){ref-type="fig"}D). We also examined the expression of *p16* ^*INK4a*^ mRNA in colonies that were chronically treated with SLIT2 and find that SLIT2 promotes *p16* ^*INK4a*^ expression in *Robo2*^+/+^ colonies and loss of *Robo2* blocks this increase ([Figure 3](#fig3){ref-type="fig"}E). These data show that loss of SLIT/ROBO2 signaling in late passage BC colonies leads to attenuated expression of *p16* ^*INK4a*^ and suggest that, similar to melanocytes, increased nuclear β-catenin in *Robo2*^*−/−*^ colonies represses *p16* ^*INK4a*^ expression and consequently inhibits senescence ([@bib8]).

To determine if loss of SLIT/ROBO2 signaling inhibits senescence, we examined senescence-associated β-galactosidase (SA-β-Gal) expression in *Robo2*^*+/+*^ and *Robo2*^*−/−*^ BC colonies. At P1, there is no difference in senescence; however, as colonies are passaged, *Robo2*^*+/+*^ colonies undergo a continual increase in senescence, whereas *Robo2*^*−/−*^ colonies maintain a fairly stable rate of senescence similar to P1 ([Figures 3](#fig3){ref-type="fig"}F and 3 G). To examine if, conversely, SLIT/ROBO2 signaling promotes senescence in BC colonies, we analyzed SA-β-Gal expression 24 and 72 hr after SLIT2 treatment. By 72 hr, colonies treated with SLIT2 display a significant increase in SA-β-Gal expression ([Figures 3](#fig3){ref-type="fig"}H and 3I) that does not occur in *Robo2*^*−/−*^ colonies ([Figure 3](#fig3){ref-type="fig"}J). Together, these data demonstrate that SLIT/ROBO2 signaling positively regulates *p16*^*INK4a*^ expression and promotes cellular senescence.

Loss of SLIT/ROBO2 Signaling Enhances MaSC Self-Renewal In Vivo {#sec2.4}
---------------------------------------------------------------

To investigate whether loss of SLIT/ROBO2 signaling impairs MaSC self-renewal in vivo, we performed serial MG transplantations. As previously demonstrated ([@bib7]), WT MG fragments can be serially transplanted four to five times, before no further outgrowths are obtained ([Figures 4](#fig4){ref-type="fig"}A, 4C, 4E, and 4G). Similar to our in vitro findings ([Figure 1](#fig1){ref-type="fig"}D), loss of *Robo1* does not confer a self-renewal advantage in the serial transplantation assay ([Figure 4](#fig4){ref-type="fig"}A). In contrast, loss of either *Robo2* or *Slit2;Slit3* leads to a nearly 2-fold increase in the number of transplant generations ([Figures 4](#fig4){ref-type="fig"}C, 4E, and 4G). These results demonstrate that loss of SLIT/ROBO2 signaling enhances MaSC self-renewal.

One explanation for the observed increased transplantability of *Robo2*^*−/−*^ and *Slit2*^*−/−*^*;Slit3*^*−/−*^ tissue is that knockout (KO) tissue contains more bMaSCs. To investigate, we analyzed MG cell populations by FACS at each generation. There is no significant increase in the percent of BCs at generation 1 (G1) in any genotype, showing that transplantation itself does not expand this population. The BC population, however, is retained at higher levels over serial transplantation in KO outgrowths. Moreover, the rate of decline of the BC population is more gradual in KO outgrowths, suggesting that bMaSCs may be retained in this tissue ([Figures 4](#fig4){ref-type="fig"}D and 4F). Because the BC population is not pure, but only enriched for bMaSCs, we also performed limiting dilution assays using BCs derived from either G0 *Robo2*^*+/+*^ or *Robo2*^*−/−*^ glands, or G4 serially transplanted *Robo2*^*+/+*^ and *Robo2*^*−/−*^ outgrowths. We found that the lack of *Robo2* in G0 glands does not result in an expansion in bMaSCs, with *Robo2*^+/+^ frequency estimated at 1/127 (95% CI 1/76--1/212) and *Robo2*^*−/−*^ frequency estimated at 1/145 (95% CI 1/87--1/241). However, we found a remarkable retention of bMaSCs in serially transplanted *Robo2*^*−/−*^ glands at G4 (*Robo2*^*+/+*^ frequency 1/1,737 (95% CI 1/753--1/4,008); and *Robo2*^*−/−*^ frequency 1/196 (95% CI 1/77--1/498). These studies show that intact *Robo2*^*−/−*^ glands do not contain more bMaSCs, but rather that *Robo2*^*−/−*^ bMaSCs do not senesce as rapidly as *Robo2*^*+/+*^ bMaSCs. In support of this hypothesis, we examined expression of *p16*^*INK4a*^ in FACS-purified cells from *Robo2*^*+/+*^ and *Robo2*^*−/−*^ transplant glands from G1 and G6. We find that, similar to P1 *Robo2*^*−/−*^ colonies ([Figure 3](#fig3){ref-type="fig"}A), *Robo2*^*−/−*^ BCs have significantly lower expression of *p16*^*INK4a*^ at G1 ([Figure 4](#fig4){ref-type="fig"}H). At G6, when *Robo2*^*+/+*^ has already senesced, we find increased levels of *p16*^*INK4a*^ in comparison to G1 levels in *Robo2*^*−/−*^ BCs, consistent with our hypothesis that loss of *Robo2* delays, but does not prevent, senescence. Taken together, the data support a model in which SLIT2 acts as a nonrenewal factor for bMaSCs by acting through ROBO2 to oppose WNT signaling, and that loss of SLIT/ROBO2 signaling delays cellular senescence by increasing the nuclear localization of β-catenin and repressing *p16*^*INK4a*^ expression.

Discussion {#sec3}
==========

Here, we show that SLITs act through ROBO2 to inhibit self-renewal of bMaSCs. The actions of SLIT/ROBO signaling on cells, including stem cells, appear to be tissue and context specific, reminiscent of the context-dependent roles this signaling pathway plays as both attractant and repellent in cell migration ([@bib3]). A recent study found that SLIT2/ROBO1 cooperates with R-spondin in intestinal stem cells to support their division and increase their self-renewal capacity, presumably by enhancing Wnt/β-catenin signaling ([@bib27]). In contrast, in this study on bMaSCs, we show an opposite effect with SLIT2 signaling through its ROBO2 receptor to limit bMaSC self-renewal by promoting senescence. Thus, although current data support an important role for SLIT signaling in modulating WNT signaling, its regulation appears to be dependent on both the cellular context in which that signal is received and the specific ROBO receptor mediating the signal. Within a single tissue, we have shown that loss of either ROBO1 or ROBO2 increases mammary BC nuclear β-catenin levels, but with very different outcomes: whereas loss of *Robo1* leads to increased cell proliferation ([@bib15]), loss of *Robo2* results in increased bMaSC self-renewal. During pregnancy a similar dichotomy of function appears to occur, with loss of *Robo1* delaying alveologenesis, whereas loss of *Robo2* enhances it (J.C. and L.H., unpublished data). Although multiple mechanisms have been shown to increase nuclear β-catenin in response to loss of SLIT/ROBO signaling ([@bib9; @bib19; @bib25]), it is not yet understood how this leads to divergent expression of WNT target genes such as those regulating proliferation and self-renewal. Determining the mechanism by which β-catenin activates and represses select WNT target genes remains a question of great interest in both the SLIT/ROBO and WNT signaling fields ([@bib1]).

Whereas SLITs have previously been characterized as mediators of adhesion, migration, and proliferation, our findings demonstrate another role for SLIT in regulating cellular senescence through its ROBO2 receptor. In identifying this function, our data further elucidate how SLIT acts as a tumor suppressor and how its loss contributes to tumor progression. A recent study found SLIT/ROBO signaling altered in 40.7% of basal, 12.3% of luminal A, and 26.3% of luminal B type tumors ([@bib18]). We show that by increasing the nuclear accumulation of β-catenin, loss of SLIT/ROBO2 signaling inhibits expression of *p16* ^*INK4a*^, itself a potent suppressor of tumors through its regulation of the cell cycle ([@bib20]). In the breast, silencing of *p16* ^*INK4a*^ generates a preclonal phase of tumorigenesis in which cells are positioned for progression to malignancy ([@bib4]). Loss of *p16*^*INK4a*^ expression also increases the percentage of cancer stem cells (CD44^+^/CD24^−^) in basal-like breast cancer cell lines and reduces their response to chemotherapeutic agents ([@bib2]). Thus, together with previous studies on SLIT signaling in the breast, current data suggest that SLITs inhibit breast tumorigenesis not only by decreasing cellular proliferation through ROBO1 ([@bib15; @bib19]), but also by promoting cellular senescence through ROBO2.

Experimental Procedures {#sec4}
=======================

Mouse Strains {#sec4.1}
-------------

*Slit2*, *Slit3*, *Robo1*, *and Robo2*^*−/−*^ mice were generated as previously described ([@bib23]). The study conforms to UCSC animal care committee (IACUC) guidelines.

Statistics {#sec4.2}
----------

Limiting dilution analysis was performed as previously described ([@bib21]). Statistics were performed using Prism software (GraphPad). Error bars in all panels represent the SEM; n = number of independent experiments, unless otherwise noted.

Transplant techniques, antibodies, IHC, SA-β-Gal assay, qRT-PCR, cell preparation, and sorting are described in [Supplemental Experimental Procedures](#app2){ref-type="sec"} (available online).
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========================
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![Loss of ROBO2 Enhances BMaSC Self-Renewal\
(A and B) (A) qRT-PCR of *Robo1* and (B) *Robo2* mRNA expression in FACS-purified basal (B), luminal progenitor (LP), and mature luminal cells (MLs). (t test: Robo2 LP ^∗^p = 0.0229, Robo2 ML ^∗^p = 0.0286; n = 3).\
(C) ROBO2 and p63 IHC on *Robo2*^*+/+*^ duct. Arrows: ROBO2 at the membrane of p63^*+*^ cells. Arrowhead: ROBO2 at the membrane of p63- cells touching the basal lamina. Bottom row: *Robo2*^*−/−*^ control. L, lumen (scale bar, 50 μm).\
(D) ROBO2/p63 IHC on *Robo2*^+/+^ basal colony. Arrows: ROBO2 in p63^+^ cells (scale bar, 50 μm).\
(E and G) Matrigel colony numbers from an initial 20K *Robo1*(E) or *Robo2*(G) cells over serial passages (G: one-way ANOVA, Bonferroni post hoc test ^∗∗∗^p = \< 0.001; two-way ANOVA, significant interaction genotype and passage ^∗∗^p \< 0.01, n = 3.\
(F and H) *Robo1*(F) and *Robo2*(H) colony size at each passage (one-way ANOVA, Bonferroni post hoc test ^∗∗∗^p \< 0.001).\
(I and J) Representative images of *Robo2* colonies at P1(I) and P5 (J) (scale bar, 250 μm; insets, 50 μm).](gr1){#fig1}

![SLIT2 Acts as a Nonrenewal Factor by Inhibiting β-Catenin Activity in bMaSCs\
(A and B) (A) Matrigel colony numbers and colony size (B) from an initial 20K control or SLIT2 (2 μg/ml) -treated WT colonies over serial passages (A: paired t test ^∗^p = 0.0482, n = 3) (B: one-way ANOVA, Bonferroni post hoc test: ^∗∗∗^p \< 0.0001, ^∗^p = 0.0261).\
(C) Colony numbers after treatment with 0.5 μg/ml SLIT2, 2 μg/ml SLIT2, 100 ng/ml WNT3A, or both over serial passages (one-way ANOVA, post hoc t test: P2: C versus 2 μg/ml SLIT2 p = 0.0492, C versus 2 μg/ml SLIT2^+^ WNT3a: p = 0.0717; P3: ^∗∗∗^p \< 0.001, n = 3).\
(D) Representative confocal images of activated-β-catenin IHC (ABC; red) and Hoechst (blue) on *Robo2* colony sections (left scale, 50 μm; right scale, 10 μm).\
(E) Relative levels of ABC expression detected using ImageJ to determine the average pixel intensity (t test: ^∗∗∗^p \< 0.001, n = 5).\
(F) qRT-PCR analysis of relative β-catenin target gene expression in *Robo2*^*+/+*^ and *Robo2*^*−/−*^ basal colonies (^∗^p = 0.0329, n = 3).\
(G) *Robo2* colony numbers at P1 and P2 of cells treated with 1 μg/ml DKK1 (two-way ANOVA, Bonferroni posttest: ^∗^p \< 0.05, n = 3).\
(H) *Robo2* colonies were cultured and passaged in the presence of DMSO or the PI3/AKT inhibitor LY294002 (5 μM) (one-tailed t test, ^∗^p = 0.0497, ^∗∗^p = 0.0049, n = 3).](gr2){#fig2}

![SLIT2/ROBO2 Signaling Promotes bMaSC Senescence by Derepressing p16^INK4a^ Expression\
(A) qRT-PCR quantification of *p16*^*INK4a*^ mRNA in P1 and P4 *Robo2* colonies (t test: P1^∗^p = 0.0185, P4 ^∗^p = 0.0119, n = 3).\
(B and C) IHC of p16 ^INK4a^ (red) and DAPI (blue) in *Robo2*^*+/+*^(B) and (C) *Robo2*^*−/−*^ P4 colonies (scale bar, 20 μm).\
(D) Quantification of p16 ^INK4a^ fluorescent intensity (n = 20--25).\
(E) qRT-PCR for *p16*^*INK4a*^ mRNA in control or SLIT2- (2 μg/ml) treated (2 weeks) *Robo2* colonies (t test:^∗^p = 0.0354, n = 3).\
(F) SA-β-gal in *Robo2* colonies over serial passages.\
(G) Low senescence P1 (top) and P4 *Robo2*^*−/−*^ colonies (bottom, right), high senescence P4 *Robo2*^+/+^ colony (bottom, left) (t test^∗^p \< 0.05; scale bar, 50 μm; n = 2--4).\
(H) Expression of SA-β-gal in SLIT2-treated colonies (t test, ^∗^p = 0.0410, ^∗∗^p = 0.0025, n = 3).\
(I) Example of low senescence (≤50% blue) control colony (top) and high senescence (\>50% blue) SLIT2-treated colony (bottom) scale bar, 50 μm.\
(J) SLIT2 induces SA-β-gal expression in *Robo2*^+/+^ colonies, but not *Robo2*^*−/−*^ colonies (paired t test ^∗^p = 0.0142, n = 3).](gr3){#fig3}

![Loss of SLIT/ROBO2 Signaling Enhances MaSC Self-Renewal In Vivo\
(A, C, and E) Fragments of littermate +/+, *Robo1*^*−/−*^ (A; n = 4), *Robo2*^*−/−*^ (C; n = 7), or *Slit2*^−/−^;*Slit3*^−/−^ (E; n = 3) MG were serially transplanted and assessed at 8 week intervals (generations) (C: t test; G3 \#p = 0.0699, G4 ^∗∗^p = 0.0033, G5 ^∗^p = 0.0403, G6 ^∗^p = 0.0182; E: paired t test; G6 ^∗∗^p = 0.0015.\
(B, D, and F) FACS analysis of basal cells within the WT, *Robo1*^−/−^ (B; n = 5--14 MG/time point \[tp\]), *Robo2*^*−/−*^ (D; n = 5--20 MG/tp), or *Slit2*^−/−^;*Slit3*^−/−^ (F; n = 5--20 MG/tp) MG (D: paired t test: G1 ^∗^p = 0.0199, G2 ^∗∗^p = 0.0077, G3 ^∗∗^p = 0.0043, G4 ^∗∗∗^p = 0.0002, G5 ^∗∗∗^p \< 0.001, G6 ^∗∗^p = 0.0022, G7 ^∗∗∗^p \< 0.0001, G8 ^∗^p = 0.0138; F: Paired t test; G4 \#p = 0.0796, G5 ^∗∗^p = 0.0038, G6 ^∗^p = 0.0184, G7 ^∗∗∗^p = 0.0002, G9 ^∗∗^p = 0.0025, G10 ^∗^p = 0.0154).\
(G) Carmine stained whole mounts from WT (top) and *Slit2*^−/−^;*Slit3*^−/−^(bottom) outgrowths (scale bar, 300 μm).\
(H) qRT-PCR of FACS-purified basal cells from *Robo2*^+/+^ and *Robo2*^−/−^ transplant glands at G1 and G6 (t test ^∗^p = 0.0271, n = 3).](gr4){#fig4}
